Biotheranostics

Commercial stage molecular diagnostics tests tailored to individual cancer patients.

placeSan Diego, California, United States calendar_todayFounded 2008 groups131 employees language biotheranostics.com

Registered entities

Innovation

20 patent families (14 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 2,060 times.

YearFilings
20158
20161
20177
20188
20194
20202
20212
20224
20233
20242
20254
20261

Investor mix

4 investors on record; lead investors include MVM; 1 has since exited.

Investor typeCountShare
Venture capital375%
Private equity125%
Coming soon